|
|
|
|
| LEADER |
00000cam a2200000Mu 4500 |
| 001 |
EBOOKCENTRAL_ocn923261025 |
| 003 |
OCoLC |
| 005 |
20240329122006.0 |
| 006 |
m o d |
| 007 |
cr |n||||||||| |
| 008 |
151010s1900 dcu o 000 0 eng d |
| 040 |
|
|
|a EBLCP
|b eng
|e pn
|c EBLCP
|d OCLCQ
|d LIP
|d OCLCF
|d ZCU
|d OCLCO
|d MERUC
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCA
|d ICG
|d AU@
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCA
|d DKC
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCA
|d OCLCQ
|d OCLCA
|d OCLCO
|d OCLCQ
|d OCL
|d OCLCO
|d OCLCL
|
| 019 |
|
|
|a 990396338
|
| 020 |
|
|
|a 9780309581523
|
| 020 |
|
|
|a 0309581524
|
| 020 |
|
|
|a 0309035449
|
| 020 |
|
|
|a 9780309035446
|
| 029 |
1 |
|
|a DEBBG
|b BV044106799
|
| 035 |
|
|
|a (OCoLC)923261025
|z (OCoLC)990396338
|
| 043 |
|
|
|a n-us---
|
| 050 |
|
4 |
|a QR189.V253
|
| 082 |
0 |
4 |
|a 338.47615372
|
| 049 |
|
|
|a UAMI
|
| 100 |
1 |
|
|a Staff, Institute of Medicine.
|
| 245 |
1 |
0 |
|a Vaccine Supply and Innovation.
|
| 260 |
|
|
|a Washington :
|b National Academies Press,
|c 1900.
|
| 300 |
|
|
|a 1 online resource (210 pages)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 588 |
0 |
|
|a Print version record.
|
| 505 |
0 |
|
|a ""Vaccine Supply and Innovation""; ""Copyright""; ""Preface""; ""Contents""; ""Vaccine Supply and Innovation""; ""1 Summary""; ""OVERVIEW""; ""VACCINE AVAILABILITY: MAJOR BARRIERS AND IMPEDIMENTS""; ""Impediments to Vaccine Innovation""; ""ECONOMIC CHARACTERISTICS OF THE VACCINE INDUSTRY""; ""VACCINE INJURY""; ""THE LEGAL SITUATION AND ITS CONSEQUENCES""; ""CONSEQUENCES OF THE STATE OF VACCINE INJURY LIABILITY LAW FOR VACCINE PRODUCTION AND INNOVATION""; ""A NATIONAL VACCINE COMMISSION""; ""COMPENSATION AND LIABILITY FOR VACCINE-RELATED INJURY""; ""2 Vaccines: Past, Present, and Future""
|
| 505 |
8 |
|
|a ""TYPES OF IMMUNIZATION""""HISTORY OF IMMUNIZATION""; ""THE PRESENT""; ""Development of Vaccines and Recommendations for Vaccine Use""; ""THE FUTURE""; ""REFERENCES AND NOTES""; ""3 Vaccine Availability: Concerns, Barriers, and Impediments""; ""CONCERNS ABOUT THE CURRENT SITUATION""; ""Supply""; ""Stockpiling of Vaccines""; ""Problems with Sole Reliance on Foreign Manufacturers""; ""Federal Action to Ensure Vaccine Supply""; ""BARRIERS AND IMPEDIMENTS TO VACCINE INNOVATION""; ""Identification of Need and Establishing Priorities""
|
| 505 |
8 |
|
|a ""Establishing the Technical Feasibility of Vaccine Development""""Economic Disincentives to Innovation and Production""; ""Factors Influencing the Market for Vaccines""; ""VACCINE UTILIZATION""; ""System Factors""; ""Client Factors""; ""Provider Factors""; ""CONCLUSIONS""; ""Barriers and Impediments to Vaccine Innovation""; ""REFERENCES AND NOTES""; ""4 Economic Aspects of Vaccine Innovation and Manufacturing""; ""POTENTIAL CAUSES OF INDUSTRY DECLINE""; ""Property Rights and Innovation""; ""Regulation""; ""Market Size""; ""Liability and Risk""; ""DESCRIPTIVE STATISTICS""
|
| 505 |
8 |
|
|a ""The Market and Participants""""Pricing""; ""Research and Development""; ""CONCLUSIONS""; ""REFERENCES AND NOTES""; ""5 Vaccine Injury""; ""The Pertussis Controversy""; ""Identifying Individuals at High Risk of Adverse Effects""; ""VACCINES USED IN CHILDHOOD""; ""Pertussis Vaccine""; ""Diphtheria Toxoid""; ""Tetanus Toxoid""; ""Poliomyelitis Vaccines""; ""Measles Vaccine""; ""Rubella Vaccine""; ""Mumps Vaccine""; ""VACCINES FOR ADULTS""; ""Influenza Vaccines""; ""Pneumococcal Vaccines""; ""Meningococcal Vaccines""; ""Rabies Vaccine""; ""Hepatitis B Vaccine""; ""SUMMARY""
|
| 504 |
|
|
|a ""REFERENCES AND NOTES""""6 Liability for the Production and Sale of Vaccines ""; ""STATE OF THE LAW""; ""Experience From the Swine Flu Vaccination Program""; ""Recent Trends""; ""The Issue of Punitive Damages""; ""Summary of the Legal Situation""; ""CONSEQUENCES OF THE STATE OF VACCINE INJURY LIABILITY LAW FOR VACCINE PRODUCTION AND INNOVATION""; ""REFERENCES AND NOTES""; ""7 An Approach to the Problems of Communication, Coordination, and Collaboration in Vaccine Policy""; ""HISTORICAL BACKGROUND""; ""THE EXISTING STRUCTURE""; ""Federal Agency Interactions""
|
| 500 |
|
|
|a ""Public-Private Sector Interactions""
|
| 546 |
|
|
|a English.
|
| 590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
| 650 |
|
0 |
|a Vaccines
|x Government policy
|z United States.
|
| 650 |
|
0 |
|a Vaccines
|x Technological innovations.
|
| 650 |
|
0 |
|a Immunization.
|
| 650 |
|
0 |
|a Vaccines.
|
| 650 |
|
0 |
|a Medical policy.
|
| 650 |
|
0 |
|a Vaccination.
|
| 650 |
|
0 |
|a Social control.
|
| 650 |
|
0 |
|a Immunotherapy.
|
| 650 |
|
0 |
|a Sociology.
|
| 650 |
|
0 |
|a Public health.
|
| 650 |
|
0 |
|a Social sciences.
|
| 650 |
|
0 |
|a National health services.
|
| 650 |
|
0 |
|a Medical care.
|
| 650 |
|
0 |
|a Biological products
|x Therapeutic use.
|
| 650 |
|
0 |
|a Therapeutics.
|
| 650 |
|
0 |
|a Biologicals.
|
| 650 |
|
0 |
|a Biological products.
|
| 650 |
|
2 |
|a Immunization
|
| 650 |
|
2 |
|a Vaccines
|
| 650 |
|
2 |
|a Health Policy
|
| 650 |
|
2 |
|a Policy
|
| 650 |
|
2 |
|a Biological Products
|
| 650 |
|
2 |
|a Vaccination
|
| 650 |
|
2 |
|a Immunotherapy, Active
|
| 650 |
|
2 |
|a Public Policy
|
| 650 |
|
2 |
|a Primary Prevention
|
| 650 |
|
2 |
|a Communicable Disease Control
|
| 650 |
|
2 |
|a Complex Mixtures
|
| 650 |
|
2 |
|a Social Control Policies
|
| 650 |
|
2 |
|a Preventive Health Services
|
| 650 |
|
2 |
|a Public Health Practice
|
| 650 |
|
2 |
|a Social Control, Formal
|
| 650 |
|
2 |
|a Immunotherapy
|
| 650 |
|
2 |
|a Immunologic Techniques
|
| 650 |
|
2 |
|a Chemicals and Drugs
|
| 650 |
|
2 |
|a Sociology
|
| 650 |
|
2 |
|a Public Health
|
| 650 |
|
2 |
|a Health Care Economics and Organizations
|
| 650 |
|
2 |
|a Investigative Techniques
|
| 650 |
|
2 |
|a Immunomodulation
|
| 650 |
|
2 |
|a Social Sciences
|
| 650 |
|
2 |
|a Health Services
|
| 650 |
|
2 |
|a Delivery of Health Care
|
| 650 |
|
2 |
|a Environment and Public Health
|
| 650 |
|
2 |
|a Biological Therapy
|
| 650 |
|
2 |
|a Health Care Facilities, Manpower, and Services
|
| 650 |
|
2 |
|a Analytical, Diagnostic and Therapeutic Techniques and Equipment
|
| 650 |
|
2 |
|a Anthropology, Education, Sociology and Social Phenomena
|
| 650 |
|
2 |
|a Therapeutics
|
| 650 |
|
2 |
|a Biological Factors
|
| 650 |
|
2 |
|a Patient Care
|
| 650 |
|
6 |
|a Vaccins
|x Politique gouvernementale
|z États-Unis.
|
| 650 |
|
6 |
|a Vaccins
|x Innovations.
|
| 650 |
|
6 |
|a Immunisation.
|
| 650 |
|
6 |
|a Vaccins.
|
| 650 |
|
6 |
|a Politique sanitaire.
|
| 650 |
|
6 |
|a Vaccination.
|
| 650 |
|
6 |
|a Contrôle social.
|
| 650 |
|
6 |
|a Immunothérapie.
|
| 650 |
|
6 |
|a Sociologie.
|
| 650 |
|
6 |
|a Santé publique.
|
| 650 |
|
6 |
|a Sciences sociales.
|
| 650 |
|
6 |
|a Services de santé.
|
| 650 |
|
6 |
|a Prestation de soins.
|
| 650 |
|
6 |
|a Biothérapie.
|
| 650 |
|
6 |
|a Thérapeutique.
|
| 650 |
|
6 |
|a Produits biologiques.
|
| 650 |
|
6 |
|a Soins médicaux.
|
| 650 |
|
6 |
|a Médicaments biologiques.
|
| 650 |
|
7 |
|a sociology.
|2 aat
|
| 650 |
|
7 |
|a public health.
|2 aat
|
| 650 |
|
7 |
|a social sciences.
|2 aat
|
| 650 |
|
7 |
|a treating (health care function)
|2 aat
|
| 650 |
|
7 |
|a Vaccines
|2 fast
|
| 650 |
|
7 |
|a Vaccination
|2 fast
|
| 650 |
|
7 |
|a Therapeutics
|2 fast
|
| 650 |
|
7 |
|a Sociology
|2 fast
|
| 650 |
|
7 |
|a Social sciences
|2 fast
|
| 650 |
|
7 |
|a Social control
|2 fast
|
| 650 |
|
7 |
|a Public health
|2 fast
|
| 650 |
|
7 |
|a National health services
|2 fast
|
| 650 |
|
7 |
|a Medical policy
|2 fast
|
| 650 |
|
7 |
|a Medical care
|2 fast
|
| 650 |
|
7 |
|a Immunotherapy
|2 fast
|
| 650 |
|
7 |
|a Immunization
|2 fast
|
| 650 |
|
7 |
|a Biological products
|x Therapeutic use
|2 fast
|
| 650 |
|
7 |
|a Vaccines
|x Government policy
|2 fast
|
| 650 |
|
7 |
|a Vaccines
|x Technological innovations
|2 fast
|
| 651 |
|
7 |
|a United States
|2 fast
|1 https://id.oclc.org/worldcat/entity/E39PBJtxgQXMWqmjMjjwXRHgrq
|
| 758 |
|
|
|i has work:
|a Vaccine supply and innovation (Text)
|1 https://id.oclc.org/worldcat/entity/E39PCFTgfHJFyDdxJvGDVdPKHP
|4 https://id.oclc.org/worldcat/ontology/hasWork
|
| 776 |
0 |
8 |
|i Print version:
|a Staff, Institute of Medicine.
|t Vaccine Supply and Innovation.
|d Washington : National Academies Press, ©1900
|z 9780309035446
|
| 856 |
4 |
0 |
|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=3376089
|z Texto completo
|
| 938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL3376089
|
| 994 |
|
|
|a 92
|b IZTAP
|
